Enhancing non-viral gene editing, processing, & expansion of T & NK cells

A key focus in cell therapy manufacturing is the development of closed, automated manufacturing processes to help reduce costs and increase the speed of getting treatments to patients. The Gibco™ CTS™ Rotea™ Counterflow Centrifugation system and the Gibco CTS Xenon™ Electroporation System are powerful modular tools in the quest towards creating a closed cell therapy manufacturing process by providing exceptional performance and helping to reduce contamination in a cell therapy manufacturing workflow. This poster provides a summary of how Thermo Fisher Scientific technologies have been proven for effective use in chimeric antigen receptor (CAR)-T cell workflow optimization and natural killer (NK) cell engineering.

Please enter your email to access content Read now